Literature DB >> 2656767

Distribution of immunoglobulin isotypes including IgA subclasses in adult, juvenile, and rapidly progressive periodontitis.

M Kilian1, B Ellegaard, J Mestecky.   

Abstract

The plasma cell population in gingival biopsies from 3 groups of patients with adult, juvenile, and rapidly progressive periodontitis was characterized with respect to the distribution of individual immunoglobulin isotypes, including IgA subclasses, by paired immunofluorescence staining. The median ratios of IgG:IgA plasma cells in gingival connective tissue from the 3 groups were 2.7 (range 2.0-6.5), 3.0 (1.4-6.2), and 2.0 (1.2-4.0), respectively. Cells staining for intracellular IgM were found in low numbers in all biopsies (range 0.3-6.3% of all plasma cells). No statistically significant differences were observed between the 3 patient groups. In all 3 groups, the IgA plasma cell population was predominantly of the IgA1 isotype. One function of IgA seems to be to dampen inflammatory side-effects of other immune effector systems. The demonstrated predominance of IgA1 plasma cells indicates that the majority of IgA produced locally in gingivae of patients with periodontal diseases is susceptible to the IgA1-specific proteases excreted by important members of the disease-associated subgingival microflora. This may be an important factor in the apparently uncontrolled inflammation and tissue degradation taking place in the marginal periodontium during active periodontal disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2656767     DOI: 10.1111/j.1600-051x.1989.tb01637.x

Source DB:  PubMed          Journal:  J Clin Periodontol        ISSN: 0303-6979            Impact factor:   8.728


  8 in total

1.  Complement-coated antibody-transfer (CCAT); serum IgA1 antibodies intercept and transport C4 and C3 fragments and preserve IgG1 deployment (PGD).

Authors:  Robert J Boackle; Quang L Nguyen; Renata S Leite; Xiaofeng Yang; Jana Vesely
Journal:  Mol Immunol       Date:  2005-03-05       Impact factor: 4.407

2.  Humoral immune responses in periodontal disease may have mucosal and systemic immune features.

Authors:  D F Kinane; D F Lappin; O Koulouri; A Buckley
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

3.  Porphyromonas gingivalis-specific serum IgG and IgA antibodies originate from immunoglobulin-secreting cells in inflamed gingiva.

Authors:  T Ogawa; Y Kono; M L McGhee; J R McGhee; J E Roberts; S Hamada; H Kiyono
Journal:  Clin Exp Immunol       Date:  1991-02       Impact factor: 4.330

4.  Bacteria in the cavity-restoration interface after varying periods of clinical service - SEM description of distribution and 16S rRNA gene sequence identification of isolates.

Authors:  Roopinder Kaur Arora; Nicola J Mordan; David A Spratt; Yuan Ling Ng; Kishor Gulabivala
Journal:  Clin Oral Investig       Date:  2022-04-01       Impact factor: 3.606

5.  Gingival mononuclear cells from chronic inflammatory periodontal tissues produce interleukin (IL)-5 and IL-6 but not IL-2 and IL-4.

Authors:  K Fujihashi; K W Beagley; Y Kono; W K Aicher; M Yamamoto; S DiFabio; J Xu-Amano; J R McGhee; H Kiyono
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

Review 6.  [Pathogenesis of parodontitis in rheumatic diseases].

Authors:  J Detert; N Pischon; G-R Burmester; F Buttgereit
Journal:  Z Rheumatol       Date:  2010-03       Impact factor: 1.372

7.  Salivary total Immunoglobulin G as a surrogate marker of oral immune activity in salivary bioscience research.

Authors:  Jenna L Riis; Crystal I Bryce; John L Stebbins; Douglas A Granger
Journal:  Brain Behav Immun Health       Date:  2019-12-03

8.  Serum and Salivary IgA, IgG, and IgM Levels in Oral Lichen Planus: A Systematic Review and Meta-Analysis of Case-Control Studies.

Authors:  Hamid Reza Mozaffari; Elisa Zavattaro; Abas Abdolahnejad; Pia Lopez-Jornet; Neda Omidpanah; Roohollah Sharifi; Masoud Sadeghi; Mohammad Shooriabi; Mohsen Safaei
Journal:  Medicina (Kaunas)       Date:  2018-12-03       Impact factor: 2.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.